Metaboliteofketamine(Cat.No.3131).IncreasesAMPAreceptor-mediatedexcitatorypost-synapticpotentialsintheCA1regionofhippocampalslices.Exhibitsantidepressiveeffectsinvivo.2S,2S-and2R,6R-enantiomersavailable.2R,6R-enantiomerlacksketamine-relatedsideeffects.
| M.Wt | 276.16 |
| Formula | C12H14ClNO2.HCl |
| Storage | DesiccateatRT |
| Purity | ≥98%(HPLC) |
| PubChemID | 121513910 |
| InChIKey | ZQJVHBJDLMIKJK-MHDYBILJSA-N |
| Smiles | ClC1=C([C@@]2(N)C([C@H](O)CCC2)=O)C=CC=C1.Cl |
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
| Solvent | MaxConc.mg/mL | MaxConc.mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 27.62 | 100 | |
| water | 27.62 | 100 |
Thefollowingdataisbasedontheproductmolecularweight276.16.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
| Concentration/SolventVolume/Mass | 1mg | 5mg | 10mg |
|---|---|---|---|
| 1mM | 3.62mL | 18.11mL | 36.21mL |
| 5mM | 0.72mL | 3.62mL | 7.24mL |
| 10mM | 0.36mL | 1.81mL | 3.62mL |
| 50mM | 0.07mL | 0.36mL | 0.72mL |



